Regulatory Considerations for Fecal Microbiota Transplantation Products
- PMID: 32053787
- DOI: 10.1016/j.chom.2020.01.018
Regulatory Considerations for Fecal Microbiota Transplantation Products
Abstract
Fecal microbiota for transplantation (FMT) is being studied as a potential intervention for numerous conditions. The regulation of FMT by the FDA is discussed along with FMT donor screening and manufacturing considerations. The FDA is committed to ensuring that FMT products can be safely tested in clinical trials.
Published by Elsevier Inc.
Comment in
-
Therapeutics Targeting the Gut Microbiome: Rigorous Pipelines for Drug Development.Cell Host Microbe. 2020 Feb 12;27(2):169-172. doi: 10.1016/j.chom.2020.01.022. Cell Host Microbe. 2020. PMID: 32053786
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical